Key result
Whole exome sequencing of a Danish family with early-onset atrial fibrillation identified a novel loss-of-function variant in CLCN2 (c.1041_1044del) that results in a truncated, non-functional ClC-2 channel.
Why the study?
The complex pathogenesis of AF is poorly understood, prompting investigation into whether genetic variation in the CLCN2 chloride channel gene is a risk factor for familial AF.
Does the CLCN2 c.1041_1044del variant alter ClC-2 channel function and associate with familial atrial fibrillation?
Observational (n=4)
Does the CLCN2 c.1041_1044del variant alter ClC-2 channel function and associate with familial atrial fibrillation?
A novel loss-of-function frameshift variant in the CLCN2 gene leads to haploinsufficiency of the ClC-2 chloride channel and is associated with early-onset familial atrial fibrillation.
May implicate CLCN2 in familial early-onset AF; extends candidate genes but remains hypothesis-generating pending replication.
Atrial Fibrillation (AF) is the most common cardiac arrhythmia. Its pathogenesis is complex and poorly understood. Whole exome sequencing of Danish families with AF revealed a novel four nucleotide deletion c.1041_1044del in CLCN2 shared by affected individuals. We aimed to investigate the role of genetic variation of CLCN2 encoding the inwardly rectifying chloride channel ClC-2 as a risk factor for the development of familiar AF. The effect of the CLCN2 variant was evaluated by electrophysiological recordings on transiently transfected cells. We used quantitative PCR to assess CLCN2 mRNA expression levels in human atrial and ventricular tissue samples. The nucleotide deletion CLCN2 c.1041_1044del results in a frame-shift and premature stop codon. The truncated ClC-2 p.V347fs channel does not conduct current. Co-expression with wild-type ClC-2, imitating the heterozygote state of the patients, resulted in a 50% reduction in macroscopic current, suggesting an inability of truncated ClC-2 protein to form channel complexes with wild type channel subunits. Quantitative PCR experiments using human heart tissue from healthy donors demonstrated that CLCN2 is expressed across all four heart chambers. Our genetic and functional data points to a possible link between loss of ClC-2 function and an increased risk of developing AF.
No takes yet. Share an insight, caveat, or question.
Hansen et al. (2020) conducted an observational in Atrial Fibrillation (n=4). CLCN2 c.1041_1044del variant vs. Wild-type CLCN2 was evaluated. Whole exome sequencing of a Danish family with early-onset atrial fibrillation identified a novel loss-of-function variant in CLCN2 (c.1041_1044del) that results in a truncated, non-functional ClC-2 channel.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: